As a follow up to the 2012 DiabetesMine Innovation Summit event held last November at Stanford University, we wanted to share the gist of the keynote talk about why the development of standards for diabetes devices and data is so crucial.
We had thought to create a white paper on the topic, but on the recommendation of the wonderful Kelly Close of Close Concerns, decided that a video version would be much more impactful; it’s…
Read more »
By
AmyT on
January 31, 2013
The fact is, a handful of manufacturers currently have a stronghold on our diabetes data. Their systems collect this vital health data for us, but are designed to withhold it so that we rely on their products exclusively to access it, share it, or analyze it.
More and more patients are finding this intolerable, and are fed up with waiting for the Pharma industry to embrace long-overdue open standards.
I’m a bit obsessed with this…
Read more »
By
AmyT on
December 5, 2012
Wow! We’re excited to welcome not one, but three senior FDA officers as joint guest posters here at the ‘Mine today. All three of these individuals attended and participated in the recent 2012 DiabetesMine Innovation Summit, which we hosted at Stanford University on Nov. 16.
Dr. Alberto Gutierrez gave an opening talk titled “How Different Constituencies Can Work Together to Improve Technology Tools for Diabetes Care” (slides here); Stayce Beck participated in our “Data and…
Read more »
By
AmyT on
November 28, 2012
To my mind, the DiabetesMine Innovation Summit I’ve hosted the last two years is not a “conference.” Rather, in the true tradition of a “Summit,” it aims to bring key decision-makers and other folks passionate about diabetes care together in one room for some very frank conversations about where we are now, what needs improvement, and how we can get to a better place as quickly as possible.
On that note, the Pharma executives and…
Read more »
